Copyright
©The Author(s) 2021.
World J Diabetes. Jun 15, 2021; 12(6): 893-907
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.893
Published online Jun 15, 2021. doi: 10.4239/wjd.v12.i6.893
Table 1 Demographic and baseline data of subjects (n = 24)
Variable | mean | SD | Min | Median | Max |
Age (yr) | 62.2 | 7.61 | 45 | 62.5 | 73 |
BMI (kg/m2) | 30.0 | 3.0 | 23.3 | 30.1 | 34.7 |
Systolic BP (mmHg) | 142.8 | 19.1 | 114.0 | 141.5 | 196.0 |
Diastolic BP (mmHg) | 88.1 | 9.1 | 73.0 | 90.0 | 105.0 |
HbA1c (%) | 6.6 | 2.6 | 5.5 | 6.6 | 7.5 |
Table 2 Blood glucose endpoints: 20 g crystal lactulose vs water
20 g crystal lactulose | Water | Treatment | P value | |||
Variable | n | LS mean (95%CI) | n | LS mean (95%CI) | Difference (95%CI) | |
AUCbaseline_c (0-180 min) (min/mmol/L) | 16 | -54.40 (-100.23, -8.57) | 16 | -53.21 (-99.14, -7.28) | -1.20 (-60.78, 58.39) | 0.9682 |
AUC(0-180 min) (min/mmol/L) | 16 | 1218.33 (1172.50, 1264.16) | 16 | 1219.53 (1173.60, 1265.46) | -1.20 (-60.78, 58.39) | 0.9682 |
iAUC(0-180 min) (min/mmol/L) | 16 | 17.00 (-14.43, 48.43) | 16 | 18.44 (-13.04, 49.92) | -1.44 (-45.16, 42.29) | 0.9478 |
Cmax (mmol/L) | 16 | 7.50 (7.17, 7.82) | 16 | 7.44 (7.11, 7.77) | 0.06 (-0.38, 0.50) | 0.7999 |
Max_increase (mmol/L) | 16 | 0.43 (0.10, 0.75) | 16 | 0.37 (0.04, 0.70) | 0.06 (-0.38, 0.50) | 0.7999 |
Table 3 Blood glucose endpoints: 30 g crystal lactulose vs water
30 g crystal lactulose | Water | Treatment | P value | |||
Variable | n | LS mean (95%CI) | n | LS mean (95%CI) | Difference (95%CI) | |
AUCbaseline_c (0-180 min) (min/mmol/L) | 16 | -30.70 (-76.75, 15.35) | 16 | -53.21 (-99.14, -7.28) | 22.51 (-37.05, 82.06) | 0.4529 |
AUC(0-180 min) (min/mmol/L) | 16 | 1242.03 (1195.98, 1288.08) | 16 | 1219.53 (1173.60, 1265.46) | 22.51 (-37.05, 82.06) | 0.4529 |
iAUC(0-180 min) (min/mmol/L) | 16 | 27.65 (-3.91, 59.21) | 16 | 18.44 (-13.04, 49.92) | 9.21 (-34.39, 52.81) | 0.6744 |
Cmax (mmol/L) | 16 | 7.77 (7.44, 8.09) | 16 | 7.44 (7.11, 7.77) | 0.33 (-0.11, 0.76) | 0.1426 |
Max_increase (mmol/L) | 16 | 0.70 (0.37, 1.02) | 16 | 0.37 (0.04, 0.70) | 0.33 (-0.11, 0.76) | 0.1426 |
Table 4 Blood glucose endpoints: 20 g liquid lactulose vs water
20 g liquid lactulose | Water | Treatment | P value | |||
Variable | n | LS mean (95%CI) | n | LS mean (95%CI) | Difference (95%CI) | |
AUCbaseline_c (0-180 min) (min/mmol/L) | 17 | -30.72 (-75.26, 13.83) | 16 | -53.21 (-99.14, -7.28) | 22.49 (-35.18, 80.16) | 0.4387 |
AUC(0-180 min) (min/mmol/L) | 17 | 1242.02 (1197.47, 1286.56) | 16 | 1219.53 (1173.60, 1265.46) | 22.49 (-35.18, 80.16) | 0.4387 |
iAUC(0-180 min) (min/mmol/L) | 17 | 34.42 (3.98, 64.86) | 16 | 18.44 (-13.04, 49.92) | 15.98 (26.78, 58.75) | 0.4578 |
Cmax (mmol/L) | 17 | 7.747 (7.43, 8.06) | 16 | 7.44 (7.11, 7.77) | 0.31 (-0.12, 0.73) | 0.1560 |
Max_increase (mmol/L) | 17 | 0.68 (0.36, 0.99) | 16 | 0.37 (0.043, 0.70) | 0.31 (-0.12, 0.73) | 0.1560 |
Table 5 Blood glucose endpoints: 30 g liquid lactulose vs water
30 g liquid lactulose | Water | Treatment | P value | |||
Variable | n | LS mean (95%CI) | n | LS mean (95%CI) | Difference (95%CI) | |
AUCbaseline_c (0-180 min) (min/mmol/L) | 15 | -41.01 (-88.72, 6.70) | 16 | -53.21 (-99.14, -7.28) | 12.20 (-47.48, 71.88) | 0.6843 |
AUC(0-180 min) (min/mmol/L) | 15 | 1231.73 (1184.02, 1279.43) | 16 | 1219.53 (1173.60, 1265.46) | 12.20 (-47.48, 71.88) | 0.6843 |
iAUC(0-180 min) (min/mmol/L) | 15 | 42.05 (9.51, 74.60) | 16 | 18.44 (-13.04, 49.92) | 23.61 (-20.52, 67.75) | 0.2890 |
Cmax (mmol/L) | 15 | 8.07 (7.73, 8.41) | 16 | 7.44 (7.11, 7.77) | 0.63 (0.19, 1.07) | 0.0059 |
Max_increase (mmol/L) | 15 | 1.00 (0.66, 1.34) | 16 | 0.37 (0.043, 0.70) | 0.63 (0.19, 1.07) | 0.0059 |
Table 6 Blood glucose endpoints: 30 g glucose vs 30 g liquid and crystal lactulose
Glucose 30 g | Liquid and crystal lactulose 30 g | Treatment | P value | ||||
Variable | n | LS mean (95%CI) | Formu-lation | n | LS mean (95%CI) | Difference (95%CI) | |
AUCbaseline_c (0-180 min) (min/mmol/L) | 16 | 459.83 (413.74, 505.92) | Liquid | 15 | -41.01 (-88.72, 6.70) | 500.84 (439.43, 562.26) | < 0.0001 |
Crystals | 16 | -30.70 (-76.75, 15.35) | 490.54 (431.89, 549.18) | < 0.0001 | |||
AUC(0-180 min) (min/mmol/L) | 16 | 1732.57 (1686.48, 1778.66) | Liquid | 15 | 1231.73 (1184.02, 1279.43) | 500.84 (439.43, 562.26) | < 0.0001 |
Crystals | 16 | 1242.03 (1195.98, 1288.08) | 490.54 (431.89, 549.18) | < 0.0001 | |||
iAUC(0-180 min) (min/mmol/L) | 16 | 481.14 (449.56, 512.72) | Liquid | 15 | 42.05 (9.51, 74.60) | 439.08 (394.55, 483.62) | < 0.0001 |
Crystals | 16 | 27.65 (-3.91, 59.21) | 453.49 (409.96, 497.02) | < 0.0001 | |||
Cmax (mmol/L) | 16 | 13.22 (12.90, 13.55) | Liquid | 15 | 8.07 (7.73, 8.41) | 5.16 (4.71, 5.61) | < 0.0001 |
Crystals | 16 | 7.77 (7.44, 8.09) | 5.46 (5.02, 5.89) | < 0.0001 | |||
Max_increase (mmol/L) | 16 | 6.15 (5.83, 6.48) | Liquid | 15 | 1.00 (0.66, 1.34) | 5.16 (4.71, 5.61) | < 0.0001 |
Crystals | 16 | 0.70 (0.37, 1.02) | 5.46 (5.02, 5.89) | < 0.0001 |
- Citation: Pieber TR, Svehlikova E, Mursic I, Esterl T, Wargenau M, Sartorius T, Pauly L, Schwejda-Guettes S, Neumann A, Faerber V, Stover JF, Gaigg B, Kuchinka-Koch A. Blood glucose response after oral lactulose intake in type 2 diabetic individuals. World J Diabetes 2021; 12(6): 893-907
- URL: https://www.wjgnet.com/1948-9358/full/v12/i6/893.htm
- DOI: https://dx.doi.org/10.4239/wjd.v12.i6.893